
Slanted Leptin Studies to Promote Drug SalesByron's Comments:This study is one of hundreds the drug-funded research community is using to create a slanted database to promote the sale of leptin drugs. The press release presents a rediculous conclusion that would never be allowed in a study - i.e., that "leptin deficiency" is a real issue needing a drug. Study Title:Leptin reverses weight loss–induced changes in regional neural activity responses to visual food stimuli.Study Abstract:From press release: Battle of the bulge: Low leptin levels undermine successful weight loss Leptin levels fall as obese individuals lose weight. So, the authors set out to see whether changes in leptin levels altered activity in the regions of the brain known to have a role in regulating food intake. They observed that activity in these regions of the brain in response to visual food-related cues changed after an obese individual successfully lost weight. However, these changes in brain activity were not observed if the obese individual who had successfully lost weight was treated with leptin. These data are consistent with the idea that the decrease in leptin levels that occurs when an individual loses weight serves to protect the body against the loss of body fat. Further, both the authors and, in an accompanying commentary, Rexford Ahima, at the University of Pennsylvania School of Medicine, Philadelphia, suggest that leptin therapy after weight loss might improve weight maintenance by overriding this fat-loss defense. Study Information:Rexford S. Ahima. Leptin reverses weight loss–induced changes in regional neural activity responses to visual food stimuli. Journal of Clinical Investigation 2008 June Full Study:http://static.the-jci.org/press/35055.pdf |
